ATC Group: A02BC01 Omeprazole

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for acid related disorders
3
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
Proton pump inhibitors
5
A02BC01
Omeprazole

Active ingredients

Active Ingredient
Description

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

Medicines in this ATC group

Drug
Countries

Australia

South Africa

Hong Kong

Tunisia

Ireland

South Africa

Hong Kong

Hong Kong

Brazil

Cyprus Hong Kong

Hong Kong Lithuania Poland

Hong Kong

Hong Kong

Tunisia

South Africa

Hong Kong

Ireland

South Africa

Hong Kong

Hong Kong

Ireland

Hong Kong

Australia Austria Brazil Canada Cyprus ...

Netherlands

Hong Kong

Australia

United Kingdom

France Tunisia

Hong Kong

Hong Kong

South Africa

Singapore

Lithuania

Singapore

Germany

Netherlands

Hong Kong

Hong Kong

Lithuania

Hong Kong

Brazil

Singapore

Singapore

Australia

Hong Kong Singapore

Finland

Hong Kong New Zealand Singapore Tunisia

Hong Kong Singapore

Singapore

Hong Kong

Hong Kong

Hong Kong

Australia

Ireland Netherlands New Zealand

Australia

Cyprus Singapore

United States

Australia New Zealand Singapore

Singapore

Singapore

Singapore

Hong Kong

United Kingdom

Singapore

Hong Kong

Lithuania

Tunisia

Singapore

Singapore

Lithuania Poland

Lithuania

Hong Kong

Hong Kong

Hong Kong Singapore

Hong Kong

Singapore

France

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
IE
Structured Product Labeling (SPL/PLR)
US